GW Pharmaceuticals
Earnings Date & Report
Last updated:
GW Pharmaceuticals’s last earnings date was on 3 May 2021. It reported its quarterly earnings per share (EPS) reaching -$0.05, beating the estimated value of -$0.36 by $0.31. The company’s quarterly earnings increased by 26.39% to 152.47M US dollars compared to the same quarter of the previous year. Over the last year, GW Pharmaceuticals’s earnings per share have grown by 79.17%.
GW Pharmaceuticals stock Earnings report, Estimates & History
| 2016-08-09 | -1.21 | -0.73 |
|---|---|---|
| 2016-12-06 | -1.14 | -0.89 |
| 2017-02-07 | -1.68 | -0.77 |
| 2017-05-09 | -1.46 | -1.7 |
| 2017-08-08 | -1.5 | -2.08 |
| 2017-12-04 | -1.67 | -2.18 |
| 2018-02-05 | -2.12 | -2.44 |
| 2018-05-08 | -2.48 | -3.12 |
| 2018-08-07 | -2.67 | -1.26 |
| 2018-11-27 | -2.51 | -2.76 |
| 2019-02-26 | -2.9 | -2.4 |
| 2019-05-06 | -2.53 | -1.68 |
| 2019-08-06 | 1.34 | 2.54 |
| 2019-11-05 | -0.85 | -0.48 |
| 2020-02-25 | -0.52 | -0.84 |
| 2020-05-11 | -0.85 | -0.24 |
| 2020-08-06 | -0.63 | -0.24 |
| 2020-11-03 | -0.83 | -0.36 |
| 2021-02-16 | -0.6 | -0.96 |
| 2021-05-03 | -0.36 | -0.05 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
GW Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 3 May 2021 | Beat | -$0.36 | -$0.05 | 157.96M | 152.46M | |
| 16 Feb 2021 | Missed | -$0.6 | -$0.96 | 143.53M | 148.22M | |
| 3 Nov 2020 | Beat | -$0.83 | -$0.36 | 315.98M | 137.05M | Earnings Call Transcript |
| 6 Aug 2020 | Beat | -$0.63 | -$0.24 | 318.40M | 121.29M | Earnings Call Transcript |
| 11 May 2020 | Beat | -$0.85 | -$0.24 | 427.24M | 120.63M | Earnings Call Transcript |
| 25 Feb 2020 | Missed | -$0.52 | -$0.84 | 67.52M | N/A | Earnings Call Transcript |
| 5 Nov 2019 | Beat | -$0.85 | -$0.48 | 161.09M | N/A | Earnings Call Transcript |
| 6 Aug 2019 | Beat | $1.34 | $2.54 | 62.86M | N/A | Earnings Call Transcript |
| 6 May 2019 | Beat | -$2.53 | -$1.68 | 59.10M | N/A | Earnings Call Transcript |
| 26 Feb 2019 | Beat | -$2.9 | -$2.4 | 23.43M | N/A | |
| 27 Nov 2018 | Missed | -$2.51 | -$2.76 | -1.17M | -1.30M | Earnings Call Transcript |
| 7 Aug 2018 | Beat | -$2.67 | -$1.26 | 4.71M | 3.42M | Earnings Call Transcript |
| 8 May 2018 | Missed | -$2.48 | -$3.12 | 2.47M | 3.34M | Earnings Call Transcript |
| 5 Feb 2018 | Missed | -$2.12 | -$2.44 | 6.57M | 7.74M | Earnings Call Transcript |
| 4 Dec 2017 | Missed | -$1.67 | -$2.18 | N/A | 3.10M | Earnings Call Transcript |
| 8 Aug 2017 | Missed | -$1.5 | -$2.08 | 2.88M | 3.13M | Earnings Call Transcript |
| 9 May 2017 | Missed | -$1.46 | -$1.7 | 1.69M | 2.02M | Earnings Call Transcript |
| 7 Feb 2017 | Beat | -$1.68 | -$0.77 | 3.51M | 2.53M | |
| 6 Dec 2016 | Beat | -$1.14 | -$0.89 | N/A | 1.90M | Earnings Call Transcript |
| 9 Aug 2016 | Beat | -$1.21 | -$0.73 | 4.34M | 3.10M | Earnings Call Transcript |
GW Pharmaceuticals Earnings report FAQs
When is GW Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest GW Pharmaceuticals's earnings date was on 11 May 2020.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.